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Impulse generation in supraventricular tissue is inhibited by adenosine and acetylcholine
via the activation of A1 and M2 receptors coupled to inwardly rectifying GIRK/KIR3.1/3.4
channels, respectively. Unlike M2 receptors, bradycardia produced by A1 receptors
activation predominates over negative inotropy. Such difference suggests that other
ion currents may contribute to adenosine chronoselectivity. In isolated spontaneously
beating rat atria, blockade of KCa2/SK channels with apamin and Cav1 (L-type) channels
with nifedipine or verapamil, sensitized atria to the negative inotropic action of the A1
agonist, R-PIA, without affecting the nucleoside negative chronotropy. Patch-clamp
experiments in the whole-cell configuration mode demonstrate that adenosine, via
A1 receptors, activates the inwardly-rectifying GIRK/KIR3.1/KIR3.4 current resulting in
hyperpolarization of atrial cardiomyocytes, which may slow down heart rate. Conversely,
the nucleoside inactivates a small conductance Ca2+-activated KCa2/SK outward
current, which eventually reduces the repolarizing force and thereby prolong action
potentials duration and Ca2+ influx into cardiomyocytes. Immunolocalization studies
showed that differences in A1 receptors distribution between the sinoatrial node and
surrounding cardiomyocytes do not afford a rationale for adenosine chronoselectivity.
Immunolabelling of KIR3.1, KCa2.2, KCa2.3, and Cav1 was also observed throughout
the right atrium. Functional data indicate that while both A1 and M2 receptors favor the
opening of GIRK/KIR3.1/3.4 channels modulating atrial chronotropy, A1 receptors may
additionally restrain KCa2/SK activation thereby compensating atrial inotropic depression
by increasing the time available for Ca2+ influx through Cav1 (L-type) channels.
Keywords: adenosine, atria, negative chronotropism and inotropism, potassium channels, L-type
voltage-sensitive calcium channels
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INTRODUCTION
Intravenous bolus of adenosine is clinically useful for prompt
conversion of paroxysmal supraventricular tachycardia to sinus
rhythm and to control ventricular contraction rate in atrial
fibrillation (Savelieva and Camm, 2008; Lim et al., 2009). The use
of the nucleoside is preferred mostly due to its rapid onset, short
half-life (ranging from 1 to 10 s) and lesser hypotensive effect as
compared to other previously recommended drugs, such as the
Cav1 (L-type) channel blocker verapamil (Blomström-Lundqvist
et al., 2003). Adenosine affects many aspects of cardiac function,
including heart rate, contractility and coronary flow through the
activation of G protein-coupled A1, A2A, A2B, and A3 receptors
(Mustafa et al., 2009). The A1 receptor promoter is highly active
in the atrium as compared to the ventricle, resulting in high
A1 receptor mRNA levels (Rivkees et al., 1999). This leads to a
dominant localization of A1 receptors in atrial cardiomyocytes
where they exert direct inhibitory effects on chronotropy and
dromotropy (Shryock and Belardinelli, 1997; Auchampach and
Bolli, 1999), as well as indirect anti-β-adrenergic inotropic
responses by opposing the responses of sympathetic nerves
activation and β1 receptors stimulation (Dobson, 1983; Romano
et al., 1991).
Like muscarinic M2 receptors which are responsible for the
negative chronotropic and inotropic effects of acetylcholine,
adenosine A1 receptor effects are mediated by hyperpolarization
of sinoatrial (SA) node cells as well as cells of the atrioventricular
node primarily by inducing outward potassium currents through
βγ subunits of G protein-coupled inwardly rectifying K+
channels (GIRK or KIR3.1/3.4) (Belardinelli and Isenberg, 1983;
Kurachi et al., 1986; Yatani et al., 1987; Mubagwa and Flameng,
2001). Due to different expression levels of A1 and M2 receptors,
the maximal GIRK/KIR3.1/3.4 current that can be activated
by endogenous adenosine is smaller than the current triggered
by cholinergic agonists (Kurachi et al., 1986). Activation of
GIRK/KIR3.1/3.4 currents causes a reduction in the action
potential duration, thereby decreasing the time available for
Ca2+ influx through Cav1 (L-type) channels and, hence, heart
rate and the force of muscle contraction in atrial myocardium
(Urquhart et al., 1993; Belardinelli et al., 1995; Neumann et al.,
1999). Negative inotropymay, however, be partially compensated
by modulation of multiple downstream targets of G proteins,
which may include Ca2+ influx through Cav1 (L-type) channels
(Wang et al., 2013). The predominant and better-studied Cav1.2
channel isoform coexist with the Cav1.3 in the SA node and
atrioventricular node where they participate in pacemaking by
different mechanisms (Mangoni and Nargeot, 2008). Despite
the extensive literature on this subject, several questions remain
unanswered concerning the contribution of distinct K+ and
Ca2+ channels to differential pharmacological responses of atrial
cardiomyocytes to both adenosine and acetylcholine.
Interestingly, it has been shown that the negative chronotropic
and inotropic responses to adenosine may be differentiated at the
postreceptor transduction level in the dog’s heart (Oguchi et al.,
1995). Supersensitive chronotropic and dromotropic effects have
also been described for adenosine during isoproterenol-infusion
in the human ventricle in vivo after heart transplantation,
whereas the nucleoside did not reduce the isoproterenol-
induced increase in contractility (Koglin et al., 1996). In this
study, we show that the negative chronotropic effect caused
by adenosine A1 receptors activation is evidenced at much
lower concentrations than the negative inotropic action of
the nucleoside, which is in clear contrast to the M2-receptor-
mediated cardiodepression operated by acetylcholine. Given the
clinical relevance of this finding and the lack of our knowledge
regarding the contribution of K+ and Ca2+ channel subtypes
to adenosine chronoselectivity, we tested the effect of the
nucleoside in the absence and in the presence of specific K+
and Ca2+ channel blockers (see Table 1) in rat atria with intact
SA rhythm and in voltage-clamp experiments using acutely
dissociated atrial cadiomyocytes. For comparison purposes, we
also evaluated whether these channel blockers modulate M2
receptors activation, since this is the predominant cholinergic
receptor subtype in atrial tissue of most mammalian species
(Peralta et al., 1987; Hulme et al., 1990; Wang et al., 2001; Krejci
and Tucek, 2002). Additionally, we investigated the regional
distribution of the involved receptors (e.g., A1 and M2) and
channels (e.g., Ca2+ and K+) in the right atrium and SA node
by immunofluorescence confocal microscopy.
MATERIALS AND METHODS
Animals
Wistar rats (Rattus norvegicus; 250–300 g) of either sex (Charles
River—CRIFFA, Barcelona, Spain; Vivarium ICBAS, Porto,
Portugal) were housed in a temperature-controlled (21◦C) room
with a regular 12:12-h light-dark cycle. The animals were
provided free access to standard laboratory chow and water.
Animal care and experimental procedures were carried out in
accordance with the UK Animals (Scientific Procedures) Act
1986 and followed the European Communities Council Directive
of 24 November 1986 (86/609/EEC) and the National Institutes
of Health Guide for Care and Use of Laboratory animals (NIH
Publications No. 80–23) revised 1996. All studies involving
animals are reported in accordance with ARRIVE guidelines for
reporting experiments involving animals (McGrath et al., 2010).
Isolated Perfused Spontaneously Beating
Rat Atria
Isolated perfused beating atria were prepared using a
previously described method (Kitazawa et al., 2009), with
some modifications. In brief, hearts were rapidly excised after
decapitation followed by exsanguination (Rodent guillotine,
Stoelting 51330), and placed in a physiological solution (Tyrode’s
solution) composed of (mM): NaCl 137; KCl 2.7; CaCl2 1.8;
MgCl21; NaH2PO4 0.4; NaHCO3 11.9; glucose 11.2 and gassed
with 95% O2 + 5% CO2 (at pH 7.4). In some of the experiments
the concentration of KCl was raised from 2.7 (see e.g., De Biasi
et al., 1989) to 4.7mM. Hearts were allowed to beat freely for a
few seconds at room temperature, to empty its blood content.
The paired rat atria with the SA node region were dissected
out, cleaned of fatty tissues, and suspended in a 14-mL organ
bath containing gassed Tyrode’s solution at 37◦C. Each auricular
appendage was tied and connected with thread to the organ
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TABLE 1 | List of used drugs and their pharmacological characteristics.
Drug Target selectivity Concentration range Supplier
Adenosine Endogenous adenosine receptor ligand 0.001–3mM Sigma-Aldrich
R-PIA Selective A1 receptor agonist 0.001–1 µM Sigma-Aldrich
CGS21680C Selective A2A receptor agonist 0.003–1 µM Sigma-Aldrich
DPCPX Selective A1 receptor antagonist
a 100 nM Sigma Aldrich
Oxotremorine Preferential M2 receptor agonist (≥98%)
b 0.003–3 µM Tocris Cookson Inc.
AF-DX 116 Preferential muscarinic M2 receptor antagonist
c 10 µM Tocris Cookson Inc.
4-AP Nonspecific voltage-dependent Kv channel blockerd 10 µM Sigma-Aldrich
Glibenclamide Selective blocker of ATP-sensitive inward rectifier KATP/KIR6 channels 10 µM Ascent Scientific
Tertiapin Q Potent blocker of inward rectifier GIRK/KIR currents with high affinity for KIR
3.1/3.4 channelse
300 nM Ascent Scientific
Apamin Selective blocker of small-conductance Ca2+-activated KCa2/SK channels
f 30 nM or 0.003–1 µM Sigma-Aldrich
Nifedipine Selective blocker of high-voltage Cav1 (L-type) channels 1 µM Sigma-Aldrich
Verapamil Selective blocker of high-voltage Cav1 (L-type) channels 1 µM or 0.03–10 µM Tocris Cookson Inc.
Mibefradil Moderately selective blocker of high-voltage Cav3 (T-type) channels. Displays
IC50 values of 2.7 µM and 18.6 µM for T-type and L-type channels, respectively
3 µM Tocris Cookson Inc.
aUsed as a selective high-affinity antagonist for adenosine A1 receptors (Ki ∼0.45 nM) with more than 700-fold selectivity over other adenosine receptors, namely the A2A receptor
(Lohse et al., 1987).
bCited as the predominant form of muscarinic receptors present in the heart of various mammalian species, including humans (Peralta et al., 1987; Hulme et al., 1990; Caulfield, 1993).
cUsed as a preferential M2 (and M4 ) receptor antagonist (pKB 7.1–7.2), the most expressed receptor in the heart (Caulfield, 1993).
dUsed as voltage-dependent Kv channel blocker (e.g., Bardou et al., 2001).
eTertiapin Q is a high affinity and potent blocker of inward-rectifier K+ currents that is widely used for inhibiting GIRK1/4 (KIR3.1/3.4) channels in the nanomolar concentration range (see
e.g., Jin and Lu, 1998; Whorton and MacKinnon, 2011).
fPrototypical potent and highly selective inhibitor of the small-conductance Ca2+-activated K+-channel (KCa2, SK); complete blockade of KCa2 (SK) currents were observed at 100 nM
apamin (Hugues et al., 1982).
bath wall and to an isometric force transducer (MLT050/D;
AD Instruments, Colorado Springs, CO, USA). Changes in
isometric tension were recorded continuously using a PowerLab
data acquisition system (Chart 5, version 4.2; AD Instruments,
Colorado Springs, CO, USA). The preparations were allowed to
equilibrate for 30–40 min. During this time, the preparations
were superfused with Tyrode’s solution and the tension was
adjusted to 9.8 mN. This procedure allows atria (with intact SA
node) to progressively recover rhythmic spontaneous beatings;
preparations with spontaneous atrial rate below 200 beats
min−1 or exhibiting rhythm variations above 10 beats min−1
during equilibrium were discarded to ensure measurements
were made in atria with intact primary pacemaker SA node
activity. None of the preparations exhibited noticeable signs
of ectopic-activity caused by secondary pacemakers, usually
related to asynchronous and abnormal contractions. Under
these experimental conditions, spontaneously beating rat atria
respond to muscarinic and β-adrenergic stimulation, but are
unaffected by the application of atropine or propranolol alone
used in concentrations high enough (10 µM) to prevent the
effects of acetylcholine (100 µM) and isoproterenol (30 nM),
respectively. Thus, myographic recordings reported in this study
include rate (chronotropic effect) and contractile force (inotropic
effect) of spontaneously beating atria measured in the absence of
cholinergic and/or adrenergic tone.
In some of the experiments, isometric tension was tested at a
fixed frequency of 240 beats min−1 commanded by electric field
stimulation of the preparations as an index of inotropy measured
without being affected by concurrent changes in chronotropy.
Electric atrial pacing (4Hz, 100V, 0.5ms) was performed using
a Grass S48 Stimulator (Quincy, MA, USA) via two platinum
electrodes positioned on each side of the preparations.
Experimental Design
After reaching a steady-state (Control values shown in
Table 2), the perfusion with Tyrode’s solution was stopped
and the preparations were incubated with increasing
concentrations of R-(-)-N6-(2-phenylisopropyl)adenosine
(R-PIA, 0.001–1 µM), a stable adenosine A1 receptor
agonist, or oxotremorine (0.003–3 µM), a muscarinic M2
receptor agonist, either in the absence or in the presence
of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 100 nM) or
AF-DX 116 (10 µM), which block A1 and M2 receptors,
respectively. Adenosine (0.001–3mM) and the adenosine A2A
receptor agonist, 2-p-(2-carboxyethyl)phenethylamino-5′-N-
ethylcarboxamidoadenosine (CGS 21680C, 0.003–1 µM), were
also tested in some of the experiments. Agonists were added
cumulatively into the bathing solution at 2 min intervals, as
this time was considered sufficient for each concentration to
equilibrate with the preparation and to cause a maximal response
under the present experimental conditions. To examine the role
of K+ and Ca2+ channel currents in the effects of adenosine
A1 and muscarinic M2 receptors activation, concentration-
response curves to R-PIA (0.001–1 µM) and oxotremorine
(0.003–3 µM) were established in the presence of the following
inhibitors: 4-aminopyridine (4-AP, 10 µM), a nonspecific
voltage-dependent Kv channel blocker, glibenclamide (10
µM), a selective blocker of ATP-sensitive KATP/KIR6 channels,
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tertiapin Q (300 nM), a blocker of GIRK/KIR channels with high
affinity for KIR3.1/3.4 channels, apamin (30 nM), an inhibitor
of small-conductance Ca2+-activated K+ (KCa2/SK) channels,
nifedipine and verapamil (1 µM), selective blockers of high
voltage-activated Cav1 (L-type) channels, and mibefradil (3
µM), a low voltage-activated Cav3 (T-type) channel blocker
(see Table 1). For the sake of data normalization, all the
inhibitors were allowed to equilibrate with the preparations at
least for 15 min before application of R-PIA or oxotremorine;
values for atrial rate (chronotropic effect) and contractile
force (inotropic effect) after reaching the equilibrium with
the receptor antagonists or ion channel inhibitors are shown
in Table 2. The concentrations of the inhibitors in this study
were within the range of channel selectivity described in the
literature. Since, blockade of K+ channels can stimulate Ca2+
influx through voltage-sensitive Cav1 (L-type) channels, we
examined the responses of the rat spontaneously beating
atria to cumulative application of verapamil (0.03–10 µM) in
the absence and presence of apamin (30 nM) or tertiapin Q
(300 nM). In another group of experiments, the myographic
effects of increasing concentrations of apamin (0.003–1 µM)
in the absence and presence of verapamil (1 µM) were also
recorded. The protocol for drug application was identical to that
described for the studies using R-PIA and oxotremorine (see
Figure 2A).
Isolation of Atrial Cardiomyocytes
Atrial cardiomyocytes were obtained by enzymatic digestion
using a Langendorff perfusion apparatus. Rat hearts were quickly
removed and washed in HEPES buffer solution (composition
inmM: NaCl 135, KCl 5, MgSO4 1.5, NaH2PO4 0.33, HEPES
10, CaCl2 0.5, D-glucose 15, adjusted to pH 7.35 with NaOH)
containing heparin (50UI/mL) at room temperature (∼20◦C).
The excised hearts were then catheterized through the aorta
and superfused retrogradely at a flow rate of 7 ml.min−1 with
a nominally calcium-free HEPES buffer solution gassed with
100% O2 at 37
◦C. Five minutes after initiating heart perfusion,
the superfusion fluid was supplemented with collagenase II
(Worthington Biochemical Corp., 148 U/ml) and protease XIV
(Sigma-Aldrich, 10U/mL) and the calcium concentration was
raised to 0.2mM. As soon as the heart became soft to the
touch, the superfusion was stopped (for about 15 min) and atria
were dissected free from the ventricles. Isolated atria were then
gently minced into small pieces with microdissecting scissors
and further digested using a plastic transfer pipette to release
single myocytes. To separate single myocytes from non-digested
tissue, the cellular suspension was filtered through a 500 µm
mesh. The cellular suspension was centrifuged 3 times at 18 g
for 3 min. The resulting pellet of each centrifugation was then
re-suspended in fresh physiological solution (described above)
containing 10mM 2,3-butanedione monoxime and increasing
concentrations of CaCl2 to steeply raise the extracellular calcium
to a final concentration of 1mM. This isolation procedure
yields∼60–70% of Ca2+ tolerant atrial cadiomyocytes with clear
myofibrilar striations. Acutely dissociated atrial cardiomyocytes
were kept at room temperature and used up to 6 h after their
isolation.
TABLE 2 | Influence of receptor antagonists and ion channel inhibitors on
chronotropism and inotropism of spontaneously beating rat atria.
Protocols Chronotropism Inotropism n
(beats.min1) (mN)
R-PIA SERIES
Control 200 ± 5 3.9 ± 0.7 40
+ DPCPX (100 nM) 220 ± 4 3.8 ± 0.2 4
+ 4-AP (10 µM) 210 ± 15 5.1 ± 0.4* 6
+ Glibenclamide (10 µM) 214 ± 26 4.8 ± 0.6* 5
+ Tertiapin Q (300 nM) 206 ± 14 3.7 ± 0.3 5
+ Apamin (30 nM) 221 ± 11 4.5 ± 0.5 8
+ Nifedipine (1 µM) 148 ± 26* 3.7 ± 1.1 5
+ Verapamil (1 µM) 160 ± 17* 3.8 ± 0.6 5
+ Mibefradil (3 µM) 169 ± 16* 3.5 ± 0.2 7
OXOTREMORINE SERIES
Control 213 ± 5 3.5 ± 0.3 17
+ AF-DX 116 (10 µM) 225 ± 13 3.2 ± 0.1 6
+ 4-AP (10 µM) 209 ± 21 4.6 ± 0.4* 5
+ Glibenclamide (10 µM) 220 ± 26 4.1 ± 0.4* 6
+ Tertiapin Q (300 nM) 228 ± 15 3.6 ± 0.5 5
+ Apamin (30 nM) 220 ± 13 4.0 ± 0.5 7
+ Nifedipine (1 µM) 142 ± 26* 3.6 ± 0.5 5
+ Verapamil (1 µM) 165 ± 17* 3.4 ± 0.4 6
+ Mibefradil (3 µM) 164 ± 15* 3.3 ± 0.2 6
VERAPAMIL SERIES
Control 205 ± 11 3.3 ± 0.3 14
+ Apamin (30 nM) 210 ± 19 3.9 ± 0.4 7
+ Tertiapin Q (300 nM) 202 ± 11 3.4 ± 0.2 5
APAMIN SERIES
Control 218 ± 6 3.4 ± 0.3 9
+ Verapamil (1 µM) 157 ± 20* 3.5 ± 0.8 7
Receptor antagonists and ion channel inhibitors were allowed to equilibrate with the
preparations during 15 min before R-PIA (0.001–1 µM), oxotremorine (0.003–3 µM),
verapamil (0.03–10 µM), or apamin (0.003–1 µM) application. Shown are values for atrial
rate (chronotropic effect) and contractile force (inotropic effect) in the absence (Control or
vehicle) and in presence of receptor antagonists and ion channel inhibitors after reaching
the equilibrium, i.e., measured immediately before incubation with R-PIA, oxotremorine,
verapamil, and apamin. The data are expressed as mean ± SEM from an n number of
individual experiments (animals). *P < 0.05 compared with the control situation before
incubation with receptor antagonists or ion channel inhibitors.
Patch-Clamp Experiments in Isolated Atrial
Cardiomyocytes
Acutely dissociated atrial cardiomyocytes were placed onto 35
mm plastic petri dishes (NunclonTM1 surface; Nunc, Roskilde,
Denmark), which were used as recording chambers mounted
on the stage of an inverted microscope. Myocytes were allowed
to adhere to the bottom of chamber for 10 min. A gravity-fed
system was used for the exchange of extracellular solution (2–3
ml.min−1), which had the following composition (inmM): NaCl
135, KCl 5, MgSO4 1.5, NaH2PO4 0.33, HEPES 10, CaCl2 1, D-
glucose 15, adjusted to pH 7.35 with 1mM NaOH. The bathing
solution was bubbled with 100% O2 at room temperature.
Atrial cardiomyocytes were voltage-clamped using the whole
cell patch-clamp configuration, as described previously (Vicente
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FIGURE 1 | Anatomical and molecular identification of the rat SA node (A–C). (A) Endocardial view of a typical rat atrial muscle-SA node preparation. Dashed
lines indicate the orientation of cuts performed on the right atrial appendage for Masson’s trichrome staining and immunofluorescence analysis. (B) High-magnification
(400x) images of Masson’s trichrome staining of SA node (dashed box) and surrounding regions; AM, atrial muscle; CT, crista terminalis; ICR, intercaval region. Red
staining, myocytes; blue staining, connective tissue. Black arrow indicates the SA node artery. (C) Montage of confocal optical sections showing immunolabelling for
connexin 43 protein (Cx43, green signal) and neurofilament 160 (NF160, red signal) throughout the right atrial appendage from the rat. Boxes depict representative
areas of the right atrium muscle and SA node used for immunolocalization of receptors and ion channels. (D) Representative confocal micrographs of the rat SA node
and neighboring atrial muscle showing immunofluorescence labeling of A1 (upper panels) and M2 (lower panels) receptors; the corresponding differential interference
contrast (DIC) images are also shown for comparison. (E) Please note that immunolabelling of A1 receptors (green) did not co-localize with vimentin (Vim) staining
(red), which was used as a fibroblast-cell marker. Similar results were obtained in six additional experiments. The white arrow indicates the SA node artery. (F)
Tridimensional surface modeling representing immunoreactivity of images depicted in panel (D). Color bar represents relative fluorescence intensity map. (G) Graph
depicting semi-quantitative analysis of A1R and M2R expression in right atria and SA node; the ordinates are immunofluorescence intensity ratio between A1R
(Continued)
Frontiers in Pharmacology | www.frontiersin.org 5 March 2016 | Volume 7 | Article 45
Bragança et al. Adenosine Chronoselectivity in Rat Atria
FIGURE 1 | Continued
and M2R staining in paired samples from the right atrium and SA node keeping the image acquisition settings constant. Positive and negative values indicate staining
predominance in contractile myocardium and SA node of the right atrium, respectively. Values are mean ± SEM; at least 3 microscopic fields were analyzed per
section of the right atrium and SA node obtained from three to seven rats. P > 0.05 indicates that no significant differences were found in the expression of A1R and
M2R between the two atrial regions.
et al., 2010). Briefly, the patch pipettes (2.80 ± 0.09 M,
n = 19) were pulled from borosilicate glass capillaries (Science
Products GmbH, GB150T-8P) and filled with an internal solution
containing (inmM): potassium gluconate 135, KCl 5, NaCl 5,
Na1/2HEPES 10, MgCl2 1, EGTA 0.1, Na2ATP 2, NaGTP 0.4
(pH 7.3 adjusted with 1mM KOH; 305 ± 5 mOsm). Only
rod-shaped myocytes with no spontaneous contractions at rest
were used for experiments. The estimated junction potential for
the filling and bathing solution combinations mentioned above
is −8.9mV (calculated with JPCalc 2.00, School of Physiology
and Pharmacology University of New South Wales). Data were
not corrected for the junction potential. Currents were recorded
with an Axopatch 200B electrometer (Axon Instruments Inc.,
USA) and stored on a PC using the pClamp 6.0.3 software
(Axon Instruments Inc., USA) and an analog digital interface
(Digidata 1200; Axon Instruments, USA). Signals were acquired
at a sampling rate of 5 kHz and filtered at 2 kHz (−3 dB, four
pole Bessel). Quantification of currents were made by measuring
the peak current 30 ms after the initial voltage step of the
command pulse, which accounts for an approximate measure
of the peak current but, away enough from the occurrence of
the fast INa, avoiding the contamination of the sodium currents.
Current amplitudes were measured in respect to “zero current,”
which was given by the current value at −40mV, a potential
where the “expected” physiological current should be zero.
Whole-cell capacitance (132 ± 6 pF, n = 9) was calculated
from the area under the curve fitted to the transient capacitive
current produced by 5mV test depolarizing step from a holding
potential of −70mV. Cells with significant leak currents were
rejected. Also, series resistance (5.5 ± 0.3 M, n = 14) were
monitored throughout the experiments and only recordings with
variation<10% were considered valid.
The holding potential (VH) was kept at −70mV, unless
otherwise specified. The Ca2+ dependence of outward K+
currents was assessed using a two-pulse protocol. A prepulse
lasting 50ms to −10mV was delivered to trigger Ca2+
influx through voltage-activated channels. The prepulse was
immediately followed by a second depolarizing pulse to +40mV
for 750ms to elicit the outward K+ current. Before evaluating
the voltage-dependence of activation, the current stability was
monitored with a set of two-pulse protocols applied every 2




Rat hearts were excised (see above) and placed in oxygenated
Tyrode’s solution at room temperature. Following heart excision
the right atrium containing the SA node region and surrounding
atrial muscle was accurately isolated. Tissue fragments were
stretched to all directions, pinned flat onto cork slices and
embedded in Shandon cryomatrix (Thermo Scientific) before
frozen in a liquid nitrogen-isopentane bath. Frozen sections with
8 µm thickness were cut perpendicular to the crista terminalis of
the right atrium (see Figure 1A). Once defrosted, tissue sections
were fixed in phosphate buffered saline (PBS) containing 50%
acetone and 2% paraformaldehyde. Following fixation, the
preparations were washed three times for 10 min each using
0.1M PBS and incubated with a blocking buffer, consisting
in fetal bovine serum 10%, bovine serum albumin 1%, Triton
X-100 0.3% in PBS, for 2 h. After blocking and permeabilization,
samples were incubated with selected primary antibodies
(Table 3) diluted in incubation buffer (fetal bovine serum 5%,
serum albumin 1%, Triton X-100 0.3% in PBS), overnight at 4◦C.
For double immunostaining, antibodies were combined before
application to tissue samples. Following the washout of primary
antibodies with PBS (3 cycles of 10 min) tissue samples were
incubated with species-specific secondary antibodies (Table 3)
in the dark for 2 h, at room temperature. Negative controls
were carried out by replacing the primary antibodies with non-
immune serum; cross-reactivity of the secondary antibodies was
tested in control experiments in which primary antibodies were
omitted. Finally, tissue samples were mounted on optical-quality
glass slides using VectaShield as antifade mounting media (H-
1200; Vector Labs) and stored in the dark at 4◦C. Observations
were performed and analyzed with a laser-scanning confocal
microscope (Olympus FluoView, FV1000, Tokyo, Japan). The
SA node region is found in close proximity to subepicardial sinus
node artery (arrow in Figure 1B). SA node is characterized by a
large number of neurofilament 160 (NF-160) positive neuronal
fibers (Dobrzynski et al., 2005) and small-size cardiomyocytes
that are negative against connexin-43 (Cx43) staining, a gap
junction protein ubiquitously expressed in the heart apart from
in nodal tissue (van Kempen et al., 1991) (Figure 1C). Cells
within the SA node are surrounded by dense connective tissue;
collagen fibers (light blue staining) can be differentiated from
cardiomyocytes (red staining) with the Masson’s trichrome
staining (Figure 1B). Vimentin was used as a fibroblast-cell
marker in immunofluorescence confocal microscopy studies
(see Figure 1E). Semi-quantification of immunofluorescence
signals was performed using the FluoView software; at least three
images per section of the right atrium and the SA node obtained
with a 600X magnification (640 × 640 pixels resolution) were
processed. The images were stored in TIFF format with the same
resolution and, subsequently, analyzed in 3D Objects Counter
plugin for ImageJ R© software version 1.50d (National Institutes
of Health). This plugin allowed us to measure the integrated
pixel density of automatically generated regions of interest
(ROI). The average integrated pixel density of all generated ROIs
of each image was used to estimate brightness intensity of the
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FIGURE 2 | Schematic representation of the protocol used for drug applications (A). Concentration-response C/R curves of oxotremorine (B,E) and R-PIA
(C,D) on the spontaneously beating rat atria in the absence (Control) and in the presence of selective M2 (AF-DX 116) and A1 (DPCPX) receptor antagonists. The
effects of oxotremorine and R-PIA in rat atria electrically-paced at a constant frequency of 240 beats per min (4Hz) are also shown for comparison (spontaneous atrial
rate in control conditions was 218 ± 4 beats.min−1, n = 10). Oxotremorine (0.003–3 µM) and R-PIA (0.001–1 µM) were applied once every 2 min at increasing
concentrations; AF-DX 116 (10 µM) and DPCPX (100 nM) were added to the incubation fluid 15 min before application of oxotremorine or R-PIA. The ordinates are
percentage of variation of spontaneous contraction rate (chronotropic effect, ii) and mechanical tension (inotropic effect, iii) compared to baseline values obtained
before application of the corresponding agonist. The data are expressed as mean ± SEM from an n number of individual experiments. #P < 0.05 compared with
agonist-induced percentage of baseline variation on chronotropy; *P < 0.05 compared with the effect of oxotremorine or R-PIA in the absence of receptor antagonists
AF-DX 116 and DPCPX, respectively.
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specific immunolabelling. Fluorescence intensity ratio for each
pair of sections was used as a semi-quantitative approach to
evaluate the relative expression of receptors and ionic channels
in the right atrium and the SA node. Of note, the acquisition
settings on the confocal microscope were kept constant in all
optical sections of the right atrium and the SA node from the
same animal. Representative images of immunofluorescence
staining were used to create tridimensional models representing
the immunereactivity intensity by means of the Interactive 3D
surface plot v2.33 plugin for ImageJ R©. Plugin settings were kept
constant in all tridimensional assemblies. The peak height and
color represent the magnitude of immunoreactivity intensity.





from Tocris Cookson Inc. (Bristol, UK). Adenosine,
4-aminopyridine (4-AP), apamin, 2,3-butanedione
monoxime, 2-p-(2-carboxyethyl)phenethylamino-5′-N-
ethylcarboxamidoadenosine (CGS21680C), 1,3-dipropyl-
8-cyclopentyl-xanthine (DPCPX), nifedipine, propranolol,
protease XIV, R-(-)-N6-(2-phenylisopropyl)adenosine (R-PIA)
were from Sigma-Aldrich (St. Louis, MO, USA); AF-DX
116, oxotremorine sesquifumarate, mibefradil and verapamil
were from Tocris Cookson Inc. (Bristol, UK); glibenclamide
and tertiapin Q were from Ascent Scientific (Bristol, UK);
Dimethylsulfoxide (DMSO), serum albumin and Triton X-100
were from Merck (Darmstadt, Germany); collagenase II was
from Worthington Biochemical Corp (Lakewood, NJ, USA).
AF-DX 116 and glibenclamide were made up in DMSO stock
solution. DPCPX was made up in 99% DMSO/1% NaOH 1
mmol L−1 (v/v). R-PIA, verapamil and nifedipine were made up
in ethanol; these solutions were kept protected from the light
to prevent photodecomposition. Other drugs were prepared in
distilled water. All stock solutions were stored as frozen aliquots
at −20◦C. Dilutions of these stock solutions were made daily
and appropriate solvent controls were done. No statistically
significant differences between control experiments, made in
the absence or in the presence of the solvents at the maximal
concentrations used (0.5% v/v), were observed. The pH of the
superfusion solution did not change by the addition of the drugs
in the maximum concentrations applied to the preparations.
Presentation of Data and Statistical
Analysis
The isometric contractions were recorded and analyzed before
and after the addition of each drug at the desired concentration.
Results were presented as percentages of variation compared to
baseline, obtained before the administration of the evaluated
drug. Concentration-response curves were fitted by non-linear
regression using GraphPad Prism 5.04 software (La Jolla, CA,
USA) function: log(inhibitor) vs. response. We assumed that
both data share best-fit values for top and bottom and a Hill
slope equal to 1; in the case of drugs (e.g., R-PIA) showing an
intermediate increase in inotropy, we considered that data share
best-fit values for bottom (constrained to −100%) in order to
estimate pIC50 values. Fitting used the least squares method.
The data are expressed as mean ± SEM, with n indicating the
number of animals used for a particular group of experiments.
With the exception of patch-clamp experiments using acutely
dissociated atrial cardiomyocytes, each rat was used to test
only one pair of drug and antagonist/inhibitor. Comparison
between concentration-response curves obtained in the absence
and in the presence of a receptor antagonist or ion channel
inhibitor was performed using two-way ANOVA followed by
the Sidak’s multiple comparison test. Individual pairs of data
were compared using paired Student’s t-test when parametric
data was considered. The means of unmatched groups were
compared using unpaired Student’s t-test withWelch’s correction
when parametric data was considered. For multiple comparisons,
one-way ANOVA followed by Dunnett’s modified t-test was used.
P< 0.05 (two-tailed) values were considered to show significant
differences between means.
RESULTS
Adenosine Acting via A1 Receptors is a
Chronoselective Atrial Depressant as
Compared to the Muscarinic M2 Receptor
Agonist, Oxotremorine
Figure 2 shows that activation of adenosine A1 and muscarinic
M2 receptors with R-PIA (0.001–1 µM) and oxotremorine
(0.003–3 µM), respectively, decreased in a concentration-
dependent manner the rate (negative chronotropic effect) and
the force (negative inotropic effect) of spontaneous contractions
of rat atria. The negative chronotropic effect of R-PIA (pIC50
7.26 ± 0.04) was evidenced at much lower (P < 0.01)
concentrations than its negative inotropic action (pIC50 6.14 ±
0.07) (Figure 2Di), whereas oxotremorine-induced depression
of both rate and tension of spontaneously beating atria was
observed in the same concentration range (pIC50 6.97 ±
0.03 and 6.81 ± 0.10, respectively; P > 0.05) (Figure 2Ei).
Adenosine (0.001–3mM) mimicked the negative chronotropic
and inotropic effects of the full A1 agonist, R-PIA (0.001–1
µM), but the effect of the natural nucleoside was 4 log units
less potent than R-PIA (Supplementary Figure 1). Reduction
of atrial rate produced by adenosine (pIC50 3.68 ± 0.09)
was preferential compared to its ability to decrease tension of
spontaneously beating atria (pIC50 2.60 ± 0.16, n = 9, P < 0.02
vs. negative chronotropy). Unlike adenosine, R-PIA transiently
increased (P < 0.05) atrial contractile force when applied in
0.03 and 0.1 µM concentrations (Figure 2Di). Likewise, the
selective adenosine A2A receptor agonist, CGS21680C, produced
a mild positive inotropic effect (maximal increase, ∼18% at
300 nM) on spontaneously beating rat atria, when this compound
was applied in a similar concentration range (0.003–1 µM)
as R-PIA (n = 5, data not shown) (see also Dobson and
Fenton, 1997). These findings suggest that the A2A receptor
has limited importance in the response to adenosine in the
isolated spontaneously beating rat atria, yet it may contribute
to increase atrial contractile force when significant negative
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TABLE 3 | Primary and secondary antibodies used in immunohistochemistry experiments.
Antigen Code Host Dilution Supplier
PRIMARY ANTIBODIES
Connexin 43 (Cx43) ab11370 Rabbit (rb) 1:700 Abcam
Neurofilament 160 (NF-160) ab7794 Mouse (ms) 1:1000 Abcam
Vimentin M0725 Mouse (ms) 1:150 Dako
Adenosine receptor A1 AB 1587P Rabbit (rb) 1:100 Chemicon
Muscarinic receptor M2 AMR-002 Rabbit (rb) 1:200 Alomone
Small-conductance Ca2+-activated K+ channel (KCa2.2) AP10032PU-N Goat (gt) 1:400 Acris antibodies
Small conductance Ca2+-activated K+ channels (KCa2.3) ab83737 Rabbit (rb) 1:300 Abcam
High voltage-activated Ca2+ (L-type) channels (Cavα2δ−1) ab2864 Mouse (ms) 1:50 Abcam
G protein-coupled inwardly rectifying K+ channels (KIR3.1) ab61191 Rabbit (rb) 1:500 Abcam
SECONDARY ANTIBODIES
Alexa Fluor 488 anti-rb A-21206 Donkey 1:1500 Molecular probes
Alexa Fluor 568 anti-ms A-10037 Donkey 1:1500 Molecular probes
Alexa Fluor 568 anti-gt A-11057 Donkey 1:1500 Molecular probes
FIGURE 3 | Concentration-response curves of R-PIA (0.001–1 µM) on the spontaneously beating rat atria in the absence (Control) and in the presence
of potassium channels blockers: 4-AP (10 µM, A,B), glibenclamide (10 µM, C,D), tertiapin Q (300nM, E,F) and apamin (30nM, G,H). Drug applications
followed the protocol depicted in Figure 2A. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A,C,E,G) and mechanical
tension (inotropic effect, B,D,F,H) as compared to baseline values obtained before application of R-PIA. The data are expressed as mean ± SEM from an n number of
individual experiments. *P < 0.05 compared with the effect of R-PIA in the absence of potassium channel blockers.
chronotropism concurrently occurs as observed with R-PIA (see
Figure 2Di).
Figures 2Dii,iii show that selective blockade of adenosine
A1 receptors with DPCPX (100 nM), significantly shifted
to the right the concentration-response curves for R-PIA
(0.001–1 µM) in the spontaneously beating rat atria. The
blocking effect of DPCPX was dependent on the concentration
(2.5, 10, and 100 nM, n = 4−6), thus indicating that the
A1 receptor must be the dominant receptor involved in
the negative chronotropic and inotropic actions of R-PIA.
Likewise, data from Figures 2Eii,iii show that depression of
rate and tension of spontaneous atrial contractions caused by
oxotremorine (0.003–3 µM) were both completely prevented
by pre-incubation with the muscarinic M2 receptor antagonist,
AF-DX 116 (10 µM). Immunolocalization studies showed that
A1 and M2 receptors are evenly expressed in SA node and
atrial cardiomyocytes (Figures 1D,F,G), thus indicating that
differences in the receptors regional distribution do not account
for adenosine chronoselectivity in spontaneously beating rat
atria.
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FIGURE 4 | Concentration-response curves of oxotremorine (0.003–3 µM) on the spontaneously beating rat atria in the absence (Control) and in the
presence of potassium channels blockers: 4-AP (10 µM, A,B), glibenclamide (10 µM, C,D), tertiapin Q (300nM, E,F), and apamin (30nM, G,H). Drug
applications followed the protocol depicted in Figure 2A. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A,C,E,G)
and mechanical tension (inotropic effect, B,D,F,H) as compared to baseline values obtained before application of oxotremorine. The data are expressed as mean ±
SEM from an n number of individual experiments. *P < 0.05 compared with the effect of oxotremorine in the absence of potassium channel blockers.
A yet unknown postreceptor transduction mechanism to
explain the negative chronotropic supersensitivity to adenosine
in the dog heart has been hypothesized (Oguchi et al.,
1995). Supplementary Figure 2, shows that adenosine negative
chronoselectivity might depend on potassium ionic currents
since it was significantly (P < 0.05) reduced by raising the
extracellular concentration of KCl from 2.7 to 4.7mM (see e.g.,
De Biasi et al., 1989). Under these conditions, the negative
inotropic effect of R-PIA (Supplementary Figure 2D) became
evident at the same concentration range (0.003–1 µM) as that
needed to slow down atrial rate (Supplementary Figure 2C),
yet no changes were detected in the atrial effects caused by
the muscarinic receptor agonist, oxotremorine (0.003–3 µM)
(Supplementary Figures 2A,B).
Blockage of G Protein-Coupled Inwardly
Rectifying K+ (GIRK/KIR) Channels, but Not
of Kv and KATP/KIR6 Channels, Counteracts
Atrial Depression Caused by A1 and M2
Receptor Agonists
Figures 3 and 4 show the concentration-response curves of R-
PIA (0.001–1µM) and oxotremorine (0.003–3µM), respectively,
in spontaneously beating rat atria obtained in the absence
(control) and in the presence of subtype-specific K+ channel
blockers.
As observed in the guinea-pig atria (De Biasi et al., 1989),
blockade of voltage-gated Kv and ATP-sensitive KATP/KIR6
channels by 4-aminopyridine (4-AP, 10 µM) and glibenclamide
(10 µM), respectively, had no significant (P > 0.05) effects
on the negative chronotropic and inotropic actions of R-PIA
and oxotremorine. Similar results were obtained when the
concentration of 4-AP was increased from 10 to 100 µM (n =
6). On their own, 4-AP (0.01–3mM, n = 5) and glibenclamide
(1–100 µM, n = 4) increased atrial inotropism (to a maximum
of 40% above control) in a concentration-dependent manner,
without affecting the rate of spontaneous atrial contractions;
when used at a 10 µM concentration, these inhibitors raised
the force of atrial contractions by no more than 25% (see
Table 2). The positive inotropic effects of 4-AP and glibenclamide
were prevented by blocking β-adrenoceptors with propranolol
(10 µM), agreeing with the hypothesis that these drugs
may depolarize cardiac sympathetic nerve terminals favoring
endogenous noradrenaline release, which may be responsible for
the increase in the force of atrial contractions (data not shown).
In contrast to voltage-gated K+ channels, inwardly rectifier
potassium channels (KIR) are more permeable to K
+ during
hyperpolarization than during depolarization. Activation of
G protein-coupled inwardly rectifying K+ channels (GIRK
or KIR3.1/3.4) by acetylcholine hyperpolarizes the resting
membrane potential, thereby reducing the probability of action
potential generation, while contributing to shorten atrial action
potentials and the effective refractory period (ERP). Tertiapin
Q (300 nM), a blocker of GIRK/KIR channels with high affinity
for KIR3.1/3.4 channels (Kodama et al., 1996; Yamada, 2002),
prevented the inhibitory effects of R-PIA and oxotremorine on
spontaneous atrial contractions (Figures 3D, 4D, respectively).
Application of Tertiapin Q did not affect spontaneous atrial
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contractions when this drug was applied alone in the 0.03–1
µM concentration range (n = 4, see Table 2), confirming that
atrial rate (chronotropic effect) and contractile force (inotropic
effect) is not under the control of adenosine and acetylcholine
endogenous tonus in the present experimental conditions (Han
et al., 2010; but see e.g., Wang et al., 2013).
Blockage of KCa2/SK Channels with
Apamin Sensitized Atria to the Negative
Inotropic Action of R-PIA, but Failed to
Affect Oxotremorine-Induced Atrial
Depression
SK channels (small conductance calcium-activated potassium
channels) are a subfamily of Ca2+-activated K+ channels. Their
activation limits the firing frequency of action potentials and
is important for regulating after hyperpolarization in many
types of electrically excitable cells. This is accomplished through
the hyperpolarizing leak of positively charged potassium ions
along their concentration gradient into the extracellular space.
Blockade of Ca2+-activated KCa2/SK channels with apamin
(30 nM) shifted to the left the concentration-response of R-PIA
(0.001–1 µM) regarding the negative inotropic component of
the A1 receptor action (pIC50 7.05 ± 0.23, n = 7, P < 0.05 vs.
control) (Figure 3H), without much affecting the action of the
nucleoside on atrial rate (pIC50 7.48 ± 0.09, n = 7, P > 0.05
vs. control) (Figure 3G). That is, pre-treatment with apamin
(30 nM) sensitized atria to the negative inotropic effect of R-
PIA in a way that the negative chronotropic and inotropic
actions of the A1 receptor agonist became evident in the same
range of concentrations (pIC50 7.48 ± 0.09 and 7.05 ± 0.23 for
chronotropism and inotropism, respectively, n = 7, P > 0.05)
(see above). Coincidently, a similar result was obtained upon
reducing the K+ gradient across the plasmamembrane by raising
the extracellular concentration of KCl from 2.7 to 4.7mM (see
Supplementary Figures 2C,D). These findings suggest that the
bradycardic and the negative inotropic actions of adenosine may
be dissociated in terms of the intracellular mechanisms being
involved. Contrariwise, apamin (30 nM), as well as changes in the
extracellular concentration of KCl, failed to affect the depressant
effects of oxotremorine (0.003–3 µM) on spontaneously beating
rat atria under the same experimental conditions (Figures 4G,H;
see also Supplementary Figures 2A,B).
Figure 5 confirms that both SA node and atrial
cardiomyocytes exhibit immunoreactivity against KIR3.1,
KCa2.2, KCa2.3, and Cav1 channels. Differences are evident
in the distribution of apamin-sensitive KCa2.2 and KCa2.3
channels, being the latter more abundant in the SA node
compared to atrial cardiomyocytes, while the opposite was
observed regarding the KCa2.2 channel. High magnifications of
these confocal micrographs counterstained with DAPI (nuclear
dye) are shown in Supplementary Figures 3, 4. Results show
that although these ion channels exhibit a mixed membranar
and cytosolic pattern, ion channels specific immunostaining
was absent from the nucleus. The lack of more convincing
sarcolemmal staining, except for the KCa2.2 channel, is a
limitation of the present study. Intracellular immunostaining
pattern of highly expressed plasma membrane proteins is
often seen in fixed cells, as primary antibodies can enter
permeabilized cells and bind to target proteins localized in the
Golgi during their trafficking to the plasma membrane or in
caveolae and/or endosomes when subject to recycling from the
plasma membrane, as part of membrane plasticity phenomena.
Fluorescent immunostaining of receptors and ion channels may
also be differently distributed at the periphery of myocytes and
in transverse tubule (T-tubule) invaginations of the sarcolemmal
membrane, both in living and permeabilized cardiomyocytes
(Balijepalli et al., 2003). Prominent T-tubule-staining pattern can
be recognized as fine fluorescent spots inside cardiac myocytes.
The functional significance of intracellular localization of plasma
membrane receptors and ion channels certainly deserves future
investigations, which are beyond the scope of this study.
Isolated Atrial Cardiomyocytes Exhibit a
Delayed Outward K+ Current that is
Dependent on Ca2+ Influx through Cav1
(L-Type) Channels
The functionality of small conductance Ca2+-activated KCa2/SK
outward channels was tested by performing voltage-clamp
experiments in acutely dissociated rat atrial cardiomyocytes
using the whole-cell patch-clamp configuration. To evaluate
the current-voltage dependence, we covered a wide range
of potentials by setting 10mV steps (of 260ms) from −130
to +60mV, while keeping the holding potential at −70mV
(Figure 6A). The corresponding voltage-intensity curves
revealed three main components (Figures 6Ai,ii). An obvious
inward rectifying component was resolved in the range of −130
to −70mV. From −50 to 0mV, we detected an inward “hump,”
whereas a typical delayed outward K+ current was observed
above +10mV. Unfortunately, this protocol could only be
applied a limited number of times, as patch seals tend to break
down due to contraction of cardiomyocytes particularly at the
most depolarized steps, thus precluding further pharmacological
manipulations. The use of cardioplegic drugs, such as 2,3-
butanedione monoxime, after the isolation procedure was out
of the question as it affects several ion channels. Lowering Ca2+
beyond a certain threshold and/or increasing the cell Ca2+
buffering capacity was also disadvantageous because it could
preclude investigation of Ca2+-activated K+ currents. Hence,
to investigate outward K+ currents over long periods of time as
required in this study (see below), a less abrasive single voltage
step (to +40mV) was performed (Figure 6B). This protocol
consisted in a brief depolarization (50 ms) to −10mV aiming
at Ca2+ influx through voltage-activated channels, which was
immediately followed by a longer depolarizing step (750 ms) to
+40mV. This was used because the resolution of the outward
current was greater when preceded by a brief depolarizing step
to −10mV as compared to the situation where the voltage
of preceding pulses was raised to −40mV or to +20mV; the
same trend was observed in cells from three different animals.
Moreover, the outward K+ current recorded at +40mV was
greater if the duration of the prepulse (to−10mV) was increased
(data not shown; see e.g., Marrion and Tavalin, 1998).
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FIGURE 5 | (A) Representative confocal micrographs of rat right atrium and SA node sections showing immunofluorescence labeling for KIR3.1 (GIRK1), KCa2.2
(SK2), KCa2.3 (SK3), and CaVα2δ−1 channel subunits (first and third columns); the corresponding differential interference contrast (DIC) images are also shown for
comparison (second and fourth columns). Last row shows cross-reactivity of secondary antibodies, Alexa Fluor 488 anti-rabbit (AF488 anti-Rb), and Alexa Fluor 568
anti-goat (AF568 anti-Gt), in which primary antibodies were omitted (see Table 3). During documentation the settings on the confocal microscope were adjusted
appropriately to show immunoreactivity for sections containing both primary and secondary antibodies and these settings were maintained when documenting
cross-reactivity of secondary antibodies ran in parallel to minimize biases during capture and printing of digital images. White arrows indicate SA node arteries. Similar
results were obtained in five additional experiments. Horizontal bar = 30 µm. (B) Tridimensional surface modeling representing immunoreactivity of images depicted in
panel (A). Color bar represents relative fluorescence intensity map. (C) Graph depicting semi-quantitative analysis of KIR3.1, KCa2.2, KCa2.3, and CaVα2δ−1
expression in right atria and SA node; the ordinates are immunofluorescence intensity ratio between KIR3.1, KCa2.2, KCa2.3, and CaVα2δ− 1 staining in paired
samples from the right atrium and SA node keeping the image acquisition settings constant. Positive and negative values indicate staining predominance in contractile
myocardium and SA node of the right atrium, respectively. Values are mean ± SEM; at least 3 microscopic fields were analyzed per section of the right atrium and SA
node obtained from three to five rats.
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FIGURE 6 | Effects of adenosine A1 receptor activation on whole-cell voltage-clamp recordings in rat atrial myocytes. (Ai) Representative currents
following a set of voltage pulses (260ms), covering a wide range of potentials, with incremental depolarization steps (10mV) from −130 to +60mV (holding voltage
−70mV) (see inset). (Aii) Corresponding current density-voltage relationship showing three different components in terms of voltage dependence: a strong inward
rectifier, an inward “hump,” and a delayed outward current. Data are expressed as mean ± SEM of four animals; recordings from three to five isolated atrial
cardiomyocytes were averaged per experimental animal. (B) Representative current traces from a triple set of double depolarizing pulses: one first step to −40, −10,
and +20mV, lasting 50ms, followed by a second pulse to +40mV, lasting 750-ms (see inset). One can notice a larger outward current at +40mV when preceded by
a prepulse to −10mV, which suggests a Ca2+-dependent current component. Panels (C,D) show current-voltage relationships obtained from currents recorded
(Continued)
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FIGURE 6 | Continued
following a set of voltage steps (−130 to 0mV, 10mV steps, holding voltage −70mV, 260ms duration each) in the absence (Control) and in the presence of R-PIA
(300 nM, Ci) and tertiapin Q (300 nM, Di) with or without R-PIA (300 nM). Data are expressed as mean ± SEM of three animals; recordings from four to five isolated
atrial cardiomyocytes were averaged per experimental animal. Panel (Cii) shown are typical recording traces showing that activation of the adenosine A1 receptor with
R-PIA (300 nM) increases the Ca2+-dependent outward current obtained following application of the double-pulse protocol consisting of one pre-pulse of 50 ms
duration to −10mV immediately followed by a second pulse to +40mV lasting 750-ms (see inset). This experiment was repeated using four cardiomyocytes isolated
from three different animals (right-hand side panel); *P < 0.01 (paired Student’s t-test) represent significant differences from control. (Ciii) Refers to normalized values
of slope conductance (calculated with measurements of −120 to −80mV) in cells obtained from three different animals in the absence (Control) and in the presence of
R-PIA (300 nM). Panel (Dii) shows similar experiments as (Ciii), but in this case tertiapin Q (300 nM) with or without R-PIA (300 nM) was used instead of R-PIA alone.
Error bars represent SEM of three animals. *,#P < 0.05 (unpaired Student’s t-test with Welch’s correction) represent significant differences from control or from
tertiapin Q alone, respectively.
The inward current “hump” detected in the current-voltage
relationship peaking at −30 and −10mV (Figure 6A) suggests
the activation of voltage-gated calcium channels allowing Ca2+
influx mainly through high-voltage Cav1 (L-type) channels
(Grant, 2009). Even though we did not perform experiments to
directly evaluate calcium dynamics, it is likely that activation
of voltage-activated calcium channels may account for the
inward current “hump” observed here. Thus, Ca2+ recruitment
through voltage-gated channels, most probably via high-voltage
Cav1 (L-type) channels, ensures coupling to small-conductance
Ca2+-activated K+ outward currents to occur as described
in central neurons (Marrion and Tavalin, 1998) and, most
importantly, in cardiac myocytes (Lu et al., 2007). In an
attempt to elucidate the differential shape of action potentials
between atrial and ventricular myocytes, Baro and Escande
(1989) found long lasting Ca2+-activated K+ outward currents
in atrial myocytes, which were sensitive to apamin. Consistent
with this report, we show here that the outward K+ current was
clearly voltage-dependent with the maximal amplitude obtained
when atrial cardiomyocytes were depolarized with a prepulse
reaching −10mV, i.e., close to the maximum activation of high-
voltage Cav1 (L-type) currents.
The Adenosine A1 Receptor Plays a Dual
Role in Atrial Cardiomyocytes by Activating
GIRK/KIR3.1/KIR3.4 and by Inhibiting
KCa2/SK Mediated Outward Currents
Depending on Cell Depolarization
Incubation of isolated atrial cardiomyocytes with the adenosine
A1 receptor agonist, R-PIA (300 nM), increased the magnitude
of the outward K+ current (Figure 6Ci) by increasing the slope
conductance 1.36 fold above the control value (Figure 6Ciii).
Figure 6Cii shows that R-PIA (300 nM) further increased the
magnitude of the outward current when this was preceded by a
brief (50 ms) depolarizing step to −10mV allowing Ca2+ influx
through high-voltage Cav1 (L-type) channels (Grant, 2009);
this trend was observed in four out of seven cells from three
different animals (right-hand side panel), but the magnitude of
the outward current in the presence of R-PIA varied considerably
reflecting heterogeneity of the cells that compose atrial muscle.
Interestingly, R-PIA (300 nM) changed significantly the kinetics
of the outward current recorded at+40mV (Figure 6Cii).
Stimulation of A1 receptors in atrial myocytes is known
to activate inwardly-rectifying GIRK/KIR3.1/KIR3.4 channels
(Belardinelli and Isenberg, 1983; Kurachi et al., 1986; Yatani
et al., 1987; Mubagwa and Flameng, 2001), which may lead
to the appearance of a slowly activating component in the
outward current (Belardinelli and Isenberg, 1983; Kurachi
et al., 1986; Banach et al., 1993; Wellner-Kienitz et al., 2000;
Lomax et al., 2003). To test this hypothesis, we investigated
the effect of the adenosine A1 receptor agonist, R-PIA
(300 nM), under blockage of GIRK/KIR3.1/KIR3.4 channels.
Pretreatment with tertiapin Q (300 nM) decreased the whole-
cell conductance (Figures 6D, 7A). More relevant to the present
context, subsequent activation of A1 receptors with R-PIA
(300 nM), still in the presence of tertiapin Q (300 nM), caused a
further decrease, instead of an increase, of the whole-cell outward
current (Figures 6Di,ii). This suggests that upon activation of the
adenosine A1 receptor, two potassium currents are altered. While
the inwardly-rectifying GIRK/KIR3.1/KIR3.4 current is enhanced,
a second current subsisting after blockage of GIRK/KIR3.1/KIR3.4
channels with tertiapin Q is inhibited by the A1 receptor agonist.
We, then, set up to investigate the nature of the R-PIA-
sensitive outward current observed under conditions of
GIRK/KIR3.1/KIR3.4 channel blockade (Figure 7). In the
presence of tertiapin Q (300 nM), application of apamin
(30 nM) to the superfusion fluid decreased further the
Ca2+-dependent delayed outward K+ current (Figure 7B).
At 30 nM concentration the current mediated by small
conductance Ca2+-activated KCa2/SK channels are supposed to
be substantially blocked by apamin (Xu et al., 2003; Tuteja et al.,
2005). Under these pharmacological restraining conditions,
subsequent application of R-PIA (300 nM) did not cause further
modifications (P > 0.10) in the outward current (Figure 7B).
Overall, these results show that (1) there is a component of the
outward current that is mediated by small conductance Ca2+-
activated KCa2/SK channels, and (2) such KCa2/SK component
is not modified further by A1 receptors activation, since R-PIA
failed to alter the whole-cell current in the presence of apamin
(30 nM).
Figure 7A shows data obtained when evaluating whole-cell
conductance using a similar pharmacological approach. The
reduction in the magnitude of the inwardly-rectifying current
caused by tertiapin Q (300 nM) was amplified by blocking
KCa2/SK channels with apamin (30 nM). Notably, blockade of
GIRK/KIR3.1/KIR3.4 and KCa2/SK channels with tertiapin Q
(300 nM) and apamin (30 nM), respectively, prevented further
changes in whole-cells conductance by application of the
A1 receptor agonist, R-PIA (300 nM) (Figures 7A,B). Thus,
electrophysiological data strongly indicate that besides activation
of inwardly rectifying GIRK/KIR3.1/KIR3.4 currents (Belardinelli
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FIGURE 7 | Activation of adenosine A1 receptors inhibits Ca
2+-activated outward KCa2/SK current in isolated rat atrial myocytes when inwardly
rectifying GIRK/KIR3 channels are blocked with tertiapin Q. (Ai) Current-voltage relationship showing strong inward rectification obtained from currents
recorded following a set of voltage steps (−130 to 0mV, 10mV steps, holding voltage −70mV, 260ms duration each) in the absence (Control) and in the presence of
tertiapin Q (300 nM), apamin (30 nM) and R-PIA (300 nM), applied cumulatively (see the inset for representative currents). Data are expressed as mean ± SEM of three
different animals; recordings from three to five isolated atrial cardiomyocytes were averaged per experimental animal. (Aii) Bar-graphs representing pooled data from
three different animals in which the average slope conductance of the inward current was normalized to the maximum obtained in the control situation, without test
drugs. In panel (B) shown are representative whole-cell voltage-clamp recording traces from double depolarization protocol held at holding potential of −70mV using
the same cell as in (Ai). Currents were elicited by a single 10 ms depolarizing pulse from −70 to −10mV followed by a 750-ms pulse to +40mV (see inset in panel Bi).
Panel (Bi) shows the effects on Ca2+-activated outward KCa2/SK currents of cumulative applications of tertiapin Q (300 nM), apamin (30 nM), and R-PIA (300 nM).
Sodium currents were truncated to facilitate visualization of effects. (Bii) Bar-graphs representing pooled data from three similar experiments in which peak current
was normalized to the maximum current obtained in the absence of added drugs (Control). All experiments were performed in the presence of E4031 (10 µM) to
prevent rapid delayed rectifier potassium currents operated by hERG channels from being activated. Error bars represent SEM of three animals. *,#P < 0.05
(unpaired Student’s t-test with Welch’s correction) represent significant differences from the control or from tertiapin Q alone, respectively; ns, not significant.
and Isenberg, 1983; Kurachi et al., 1986; Yatani et al., 1987;
Mubagwa and Flameng, 2001), stimulation of adenosine A1
receptors leads to inhibition of apamin-sensitive Ca2+-activated
KCa2/SK channels in atrial cardiomyocytes.
Loss of Atrial Chronoselectivity of
Adenosine A1 Receptors by Blocking High
Voltage-Activated Cav1 (L-Type) Currents
with Nifedipine or Verapamil
The KCa2/SK channel gating mechanism is controlled by
intracellular Ca2+ levels entering via voltage-activated calcium
channels (Cav) (Marrion and Tavalin, 1998). Figure 8 shows
that blockade of Cav1 (L-type) channels with nifedipine or
verapamil, applied in a concentration (1 µM) that reduced atrial
chronotropy roughly by 25% (see Table 2), sensitized atria to the
negative inotropic action of R-PIA (0.001–1 µM) without much
affecting the action of the A1 receptor agonist on atrial rate.
The negative chronotropic and inotropic actions of R-PIA were
both evident at the same concentration range in the presence of
Cav1 (L-type) channel blockers, nifedipine (pIC50 7.51 ± 0.10
and 7.14 ± 0.14 for chronotropism and inotropism, respectively,
n = 5, P > 0.05) or verapamil (pIC50 7.80 ± 0.20 and 7.34 ±
0.24 for chronotropism and inotropism, respectively, n = 5, P >
0.05), thus resulting in a loss of the atrial chronoselectivity of
adenosine A1 receptors (see above). Under similar experimental
conditions, pre-treatment with acetylcholine did not significantly
(P > 0.05) modify the depressing effects of R-PIA (0.001–1
µM) on spontaneously beating rat atria, when the cholinergic
agonist was applied in a concentration (30 µM) that mimicked
the negative chronotropic effect (25% reduction from control,
n= 3–4) of nifedipine or verapamil. Conversely, blockade Cav1
(L-type) channels with 1 µM nifedipine or verapamil failed
to modify oxotremorine (0.003–3 µM)-induced depression in
the rat spontaneously beating atria (Figure 9). These findings
contrast with those obtained with the adenosine A1 receptor
agonist, suggesting that the negative chronotropic and inotropic
actions of oxotremorine are independent on Ca2+ influx through
Cav1 (L-type) channels and on apamin-sensitive KCa2/SK
channels, relying most probably on the control of K+ currents
via G protein-coupled inwardly rectifying K+ channels (GIRK or
KIR3.1/3.4) sensitive to tertiapin Q.
Blockade of low voltage-activated Cav3 (T-type) channels with
mibefradil (0.1–10 µM) concentration-dependently reduced
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FIGURE 8 | Concentration-response curves of R-PIA (0.001–1 µM) on the spontaneously beating rat atria in the absence (Control) and in the presence
of voltage-sensitive calcium channels inhibitors: nifedipine (1 µM, A,B), verapamil (1 µM, C,D), and mibefradil (3 µM, E,F). Drug applications followed the
protocol depicted in Figure 2A. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A,C,E) and mechanical tension
(inotropic effect, B,D,F) as compared to baseline values obtained before application of R-PIA. The data are expressed as mean ± SEM from an n number of individual
experiments. *P < 0.05 compared with the effect of R-PIA in the absence of voltage-sensitive calcium channels inhibitors.
FIGURE 9 | Concentration-response curves of oxotremorine (0.003–3 µM) on the spontaneously beating rat atria in the absence (Control) and in the
presence of voltage-sensitive calcium channels inhibitors: nifedipine (1 µM, A,B), verapamil (1 µM, C,D), and mibefradil (3 µM, E,F). Drug applications
followed the protocol depicted in Figure 2A. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A,C,E) and mechanical
tension (inotropic effect, B,D,F) as compared to baseline values obtained before application of oxotremorine. The data are expressed as mean ± SEM from an n
number of individual experiments.
atrial chronotropy to a maximum of 30% (n = 7), without
affecting the force of spontaneous atrial contractions (see
Table 2). Mibefradil (3 µM) failed to modify the effects of both
R-PIA (0.001–1 µM, Figures 8E,F) and oxotremorine (0.003–3
µM, Figures 9E,F) in the spontaneously beating rat atria (see also
Belardinelli et al., 1995).
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Interplay between KCa2/SK, GIRK/KIR, and
Cav1 (L Type) Channels on Spontaneously
Beating Rat Atria
Figure 10 shows the responses of spontaneously beating rat atria
to the cumulative application of verapamil (0.03–10 µM) in
the absence and presence of apamin (30 nM) or tertiapin Q
(300 nM). Verapamil (0.03–10 µM), as well as nifedipine (0.03–
30 µM, data not shown), decreased the rate of contractions of
the rat spontaneously beating atria in a concentration-dependent
manner. Similarly to adenosine A1 receptor agonist, the negative
chronotropic effect of verapamil (0.03–10 µM, Figures 10A,C)
was evidenced in concentrations unable to decrease the
magnitude of atrial tension (Figures 10B,D). It is worth noting
that the negative inotropic potency of R-PIA (Figure 2C) and
verapamil (data not shown) was not significantly (P > 0.05)
modified in atria paced electrically at a constant frequency of
240 beats.min−1; for instance, the pIC50 values obtained for the
negative inotropic action of R-PIA were not different (P > 0.05)
in spontaneously beating (6.14 ± 0.07, n = 38) and electrically-
paced (6.20 ± 0.05, n = 7) rat atria. A similar situation was
detected regarding the negative inotropic effect of oxotremorine
in spontaneously beating (pIC50 value of 6.81 ± 0.10, n =
31) and electrically-paced (pIC50 value of 7.22 ± 0.15, n = 7)
atria (Figure 2B). These findings were obtained notwithstanding
the maximal reduction of myographic recordings amplitude
induced by pacing in the presence of R-PIA and oxotremorine
did not go beyond 30% of that observed in spontaneously
beating atria (see Figure 2B). Thus, data indicate that sustained
inotropy is not a direct consequence of the intracellular residual
Ca2+ accumulation due to slowing down the rhythm of
atrial contractions (negative dromotropic/chronotropic effects)
in response to drug applications. However, in contrast to
the adenosine A1 receptor agonist, blockade of KCa2/SK and
GIRK/KIR channels respectively with apamin (30 nM) and
tertiapin Q (300 nM) failed to modify atrial effects produced by
verapamil (0.03–10 µM).
In another set of experiments, we tested the effects of
increasing concentrations of apamin (0.003–1 µM) in the
absence and in the presence of verapamil (1 µM) (Figure 11).
Blockade of Ca2+-activated KCa2/SK channels with apamin
(0.003–1 µM) did not significantly (P > 0.05) change the
spontaneous atrial rate (Figure 11A), but we observed a
moderate positive inotropic effect (maximal increase ∼20%
at 0.1 µM, Figure 11B) in line with that occurring with
other K+ channel blockers, 4-AP and glibenclamide (see
above). Interestingly, the mild positive inotropic effect of
apamin (0.003–1 µM) reproduced the transient increase in
atrial contractile force caused by the adenosine A1 receptor
agonist, R-PIA, in a wide range of concentrations (1–100 nM,
see Figure 2), but the KCa2/SK channel inhibitor had no
comparable effect on chronotropy. Verapamil (1 µM) reversed
the positive inotropic effect of apamin leading to a mild negative
inotropic effect (Figure 11B). Data suggest that strengthening
spontaneous atrial contractions by blocking KCa2/SK channels
requires Ca2+ influx through verapamil-sensitive Cav1 (L type)
channels.
FIGURE 10 | Concentration-response curves of the Cav1 (L-type)
channel inhibitor, verapamil (0.03–10 µM), on the spontaneously
beating rat atria in the absence (Control) and in the presence of
apamin (30nM, A,B) and tertiapin Q (300nM, C,D), which selectively
block KCa2/SK and GIRK/KIR channels, respectively. Drug applications
followed the protocol depicted in Figure 2A. The ordinates are percentage of
variation of spontaneous contraction rate (chronotropic effect, A,C) and
mechanical tension (inotropic effect, B,D) as compared to baseline values
obtained before application of verapamil. The data are expressed as mean ±
SEM from an n number of individual experiments.
DISCUSSION
The present study demonstrates that adenosine and its
stable analog, R-PIA, acting via inhibitory A1 receptors are
chronoselective atrial depressants affecting inotropy in a much
lesser degree compared to the muscarinic M2 receptor agonist,
oxotremorine, in spontaneously beating rat atria. Likewise,
intravenous R-PIA caused a marked and sustained sinus
bradycardia without affecting myocardial contractility leading to
a reduction in the mean arterial blood pressure in anesthetized
pigs (Wainwright and Parratt, 1993). A different result was
obtained by Lee et al. (1993), since the A1 receptor agonist,
N6-cyclopentyladenosine (CPA), was about equipotent on
electrically-driven left atria (negative inotropic action) and on
spontaneously beating right atria (negative chronotropic action).
However, these authors used a pacing frequency of 1Hz (60
beats.min−1) that is far too low compared to the spontaneous
atrial rate (200–220 beats.min−1) as verified in our study using
both right and left atria with the SA node intact (see Table 2). We
show here that activation of the A1 receptor with R-PIA decreases
the contractile force of atria paced at 4Hz frequency (just slightly
above the spontaneous atrial rate) by a similar extent to that
observed in spontaneously beating atria. In anesthetized pigs,
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FIGURE 11 | Concentration-response curves of the KCa2/SK channel
blocker, apamin (0.003–1 µM), on the spontaneously beating rat atria in
the absence (Control), and in the presence of verapamil (1 µM). Drug
applications followed the protocol depicted in Figure 2A. The ordinates are
percentage of variation of spontaneous contraction rate (chronotropic effect,
A) and mechanical tension (inotropic effect, B) as compared to baseline values
obtained before application of apamin. The data are expressed as mean ±
SEM from an n number of individual experiments. *P < 0.05 compared with
the effect of apamin in the absence of verapamil.
right atrial pacing with a frequency just above the spontaneous
sinus rate in the pig (110 beats.min−1) abrogated R-PIA-induced
decrease in blood pressure, showing that the fall in blood pressure
seen in unpaced animals was a result of decreased cardiac rate
and was not due to a reduction in myocardial contractility
and/or to peripheral vasodilatation. These findings indicate
that negative chronotropic-dependent inotropy, which has been
pointed out as a major drawback of experiments performed in
spontaneously beating isolated atria (Stemmer and Akera, 1986),
does not account significantly to adenosine chronoselectivity.
Supersensitive negative chronotropic and dromotropic effects of
adenosine have been described in the presence of isoproterenol
in the transplanted human heart in which adenosine failed
to attenuate the isoproterenol-induced increase in contractility
whereas it produced an exaggerated negative chronotropic and
dromotropic effect (Koglin et al., 1996). Isolated spontaneously
beating atria as used in the present study are devoid of
counterregulatory inotropic actions of the sympathetic nervous
system. A remaining stimulation of β1-adrenoceptors can also
not afford a valid explanation for adenosine chronoselectivity
in our study since atria were unaffected by the application of
propranolol (Dobson, 1983; Romano et al., 1991).
Immunofluorescence confocal microscopy showed no
significant differences in the distribution of the A1 receptor
protein between SA node and atrial cardiomyocytes
suggesting that it can also not afford a rationale for adenosine
chronoselectivity (see Figure 1D). This was observed despite
the demonstration that the A1 receptor mRNA expression
was higher in the right atrium than in the SA node, with
no differences found on M2 receptor mRNA levels between
distinct atrial regions (Chandler et al., 2009). These findings
suggest that the negative chronotropic and inotropic atrial
responses to adenosine, via A1 receptors, are differentiated
at the postreceptor transduction level (see e.g., Oguchi et al.,
1995). While both A1 and M2 receptors promote K
+ eﬄux
through βγ subunits of G protein-coupled inwardly rectifying
(tertiapin Q-sensitive) GIRK/KIR3 channels modulating SA node
automatism (Belardinelli and Isenberg, 1983; Kurachi et al.,
1986; Yatani et al., 1987; Mubagwa and Flameng, 2001), we
demonstrated here for the first time that activation of adenosine
A1 receptors concurrently inhibit small conductance outward
KCa2/SK currents probably via G protein α subunit.
Cardiac K+ channels have been recognized as potential
targets for the actions of neurotransmitters, hormones and
class III antiarrhythmic drugs that prolong action potential
duration and refractoriness; potassium channel inhibitors can
effectively prevent/inhibit cardiac arrhythmias (Li and Dong,
2010). Among all K+ channel inhibitors used in this study,
namely 4-aminopyridine, glibenclamide, and apamin, only the
selective GIRK/KIR3.1/3.4 channel blocker, tertiapin Q, produced
no significant effects on spontaneously beating atria when
used alone. It is, therefore, reasonable to conclude that the
primary effect of tertiapin Q on spontaneously beating atria
is limited to blockade of muscarinic- and adenosine-activated
GIRK/KIR3.1/3.4 currents and that, in the absence of endogenous
ligands, both atrial rate and contractile force are not controlled
by constitutive A1 and M2 receptors activity. Scarcity of intrinsic
A1 receptor tone in the absence of endogenous adenosine was
also inferred from the lack of effect of DPCPX (2.5–100 nM)
alone on spontaneous atrial performance, as this compound
has inverse agonist properties in systems with constitutive A1
receptor activity (Searl and Silinsky, 2012; He et al., 2013). Besides
tertiapin Q, the repercussion of K+ channels blockade on atrial
activity may reflect a positive inotropic effect operated either
directly due to cardiomyocyte depolarization, or indirectly by
promoting noradrenaline release from depolarized sympathetic
nerves associated to blockage of outward K+ currents at resting
membrane potential (Lawson, 1996; Xu et al., 2003; Tuteja et al.,
2005; Grant, 2009). The participation of noradrenaline release
from sympathetic nerves was assumed because the inotropic
effect of K+ channel inhibitors was prevented by the β-receptor
blocker, propranolol.
Moreover, the resting heart rate in unrestrained conscious
wild-type and GIRK4 knockout mice was virtually identical,
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indicating that other signaling pathways involved in heart rate
regulation might balance the missing IKACh current (Wickman
et al., 1998). These authors showed that the diminished
bradycardic response of the GIRK4 knockout mice to A1 receptor
activation was only fifty percent of the heart rate decrease in
response to adenosine and acetylcholine in vivo. Therefore, they
hypothesized that the residual bradycardic effect of adenosine
and acetylcholine in the knockout mice may be due to decreases
in slow depolarizing currents, namely cationic (If), and sustained
inward (IST) currents, which are directly or indirectly modulated
by the cyclic AMP pathway. The opposite was however detected
in our hands, where blockade of GIRK/KIR3.1/3.4 currents
with tertiapin Q reduced, instead of increasing, the whole-cell
inward current caused by the A1 receptor agonist, R-PIA, in
rat atrial cardiomyocytes (Figure 6). Besides ivabradine analogs
(e.g., zatebradine), which produce use-dependent inhibition
of hyperpolarization-activated mixed Na+-K+ inward current
If (cyclic nucleotide-gated HCN channel) in sinoatrial node
cells but also significantly reduce voltage-gated outward K+
currents (IK) at the same concentrations, there are no other
specific pharmacological manipulators to dissect the influence
of these currents in the spontaneously beating rat atria. Yet, we
found no differences in spontaneous atrial rate and inotropy
upon applying the cyclic AMP-specific phosphodiesterase type
4 inhibitor rolipram (1–100 µM) (unpublished observations),
showing that under the present experimental conditions cyclic
nucleotide-gated currents play a minor role. Moreover, in vivo
data supports a greater role for If currents in His-Purkinje fibers
vs. SAN tissue. In support of our hypothesis, immunolocalization
studies with an antibody specific for GIRK1/KIR3.1 demonstrates
that the distribution of this channel subtype follows a similar
pattern of both A1 and M2 receptors in SA node and atrial
cardiomyocytes (Figure 5).
Blockade of voltage-dependent Kv with 4-AP and ATP-
sensitive KATP/KIR6 channels with glibenclamide failed tomodify
atrial depression caused by adenosine A1 and muscarinic M2
receptor agonists in spontaneously beating rat atria, when the K+
channel inhibitors were applied in concentrations as high as 10
µM. Likewise, 4-AP and blockade of the rapid delayed rectifier
potassium current (IKr) operated by hERG channels with E4031
did not modify cardiac responses to adenosine in isolated blood-
perfused atria of the dog (Oguchi et al., 1995). These findings
rule out the involvement of voltage-dependent Kv cannels on
the inhibitory effects of A1 and M2 agonists and confirm data
from interaction studies between 4-AP (0.3–3mM) and R-PIA
in the guinea-pig using spontaneously beating and electrically-
driven atria (De Biasi et al., 1989). Concerning the lack of effect
of glibenclamide in antagonizing the responses to M2 and A1
receptor agonists in rat atria, our results agree with previous
reports in the guinea-pig indicating that cardiodepression by
these agents are not operated by ATP-sensitive KATP/KIR6
channels (Urquhart et al., 1993; Ford and Broadley, 1999).
Due to high sensitivity of KCa2/SK channels for Ca
2+
activation yielding half maximal activation at ∼300 nM [Ca2+]i
with a Hill coefficient between 4 and 5 (Xia et al., 1998), these
channels aid in integrating changes in intracellular free Ca2+
concentration with membrane potential in the late phase of
cardiac repolarization. The small conductance Ca2+-activated
SK potassium channel subfamily differs in apamin sensitivity,
with the SK2 (KCa2.2) being more sensitive (IC50 ∼ 70 pM)
than the SK3 (KCa2.3) (IC50 ∼ 0.63–6 nM), while a more
pronounced expression of these channels exist in atria compared
with ventricle myocytes of different species (Xu et al., 2003;
Jager and Grissmer, 2004; Tuteja et al., 2005). Data from
immunolocalization studies indicate that the apamin-sensitive
SK2 (KCa2.2) channel seems to be more abundant in atrial
cardiomyocytes than in the SA node (Figure 5), while the
opposite is observed with the SK3 (KCa2.3) channel (cf. Tuteja
et al., 2005). Preferential co-localization of SK2 (KCa2.2) channels
and A1 receptors in atrial cardiomyocytes, rather than in SA
node, might explain why apamin sensitized (by more than 10
fold) atria to the negative inotropic action of the A1 receptor
agonist, R-PIA, without significantly affecting the chronotropic
effect of the nucleoside. In theory, the leftward shift caused by
apamin of the concentration-response curve of R-PIA regarding
its negative inotropic effect was unexpected, considering that
inhibition of repolarizing KCa2/SK currents should prolong
the action potential duration and, thereby, increase the time
available for Ca2+ influx through Cav1 (L-type) channels leading
to a positive inotropic response. In fact, apamin alone caused
a mild (<20%) positive inotropic response (with no effect
on chronotropy) which was counteracted by the Cav1 (L-
type) channel inhibitor, verapamil (Figure 11). Controversy
still exists in the literature regarding the effect of KCa2/SK
channel blockers on action potential duration that derive from
interspecies differences, experimental idiosyncrasies (e.g., paced
vs. unpaced, high vs. low pacing rates), uneven expression of
channels throughout atria and unusual pharmacological profiles
due to SK2-SK3 channels heteromerization (see e.g., Xu et al.,
2003; Nagy et al., 2009; Hancock et al., 2015). Apart from
this dispute, we agree with other authors that action potential
repolarization is controlled by a, not yet fully characterized, fine
balance between various transmembrane ionic currents that are
essential to determine the duration of the cardiac action potential.
One possible explanation for the above disparity could be that
blockade of KCa2/SK channels stabilizes the K
+ gradient across
the cell membrane at a higher level (Xu et al., 2003), leading
to increased GIRK/KIR3.1/3.4-mediated K
+ eﬄux and cell
hyperpolarization per G protein-coupled receptor activated, thus
affecting the relative potency of the A1 receptor agonist. If this
were the case, apamin should have also potentiated the negative
inotropic effect of the M2 receptor agonist in a similar manner
to that observed with the A1 agonist, taking into consideration
that both receptors couple to GIRK/KIR3.1/3.4 channels (Kurachi
et al., 1986). However, atrial depression caused by oxotremorine
was not affected by apamin, indicating that Ca2+-activated
KCa2/SK channels are not involved in muscarinic M2 receptors
activity. Activation of KCa2/SK currents causes a hyperpolarizing
leak of potassium ions from the cell in favor of its concentration
gradient. Therefore, increases in the extracellular potassium
concentration should mimic blockage of these currents by
apamin. Coincidently, both apamin and augmentation of
the extracellular concentration of potassium (from 2.7 to
4.7mM) sensitized atria to the negative inotropic effect of
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the A1 receptor agonist, without affecting adenosine negative
chronotropy. Neither apamin nor increases in the extracellular
K+ concentration affected significantly oxotremorine-induced
cardiodepression in spontaneously beating rat atria. We are
aware that increases in extracellular K+ has many effects on
excitable cells, yet under our experimental conditions this
approach positively discriminated the A1 receptor-mediated
negative inotropic effect by shifting to the left the concentration-
response curve of the adenosine analog, R-PIA, without affecting
the muscarinic atrial depression.
The most plausible explanation might be that inactivation of
KCa2/SK outward currents caused by adenosine A1 receptors (via
G protein α subunit) in the late phase of atrial repolarization
may prolong the action potential duration and shift the resting
membrane potential of cardiomyocytes toward more depolarized
potentials resulting in an increase in the net Ca2+ influx
through Cav1 (L-type) channels (cf. Lu et al., 2007; Skibsbye
et al., 2015). This hypothesis may be challenged by a recent
report showing that in right atria paced at 5Hz frequency
both acetylcholine and the A1 receptor agonist, CPA, shortened
action potential duration at 90% repolarization (APD90) and
the ERP in a tertiapin Q-sensitive manner (Wang et al., 2013).
However, in contrast to our work using spontaneously beating
atria, these authors found a basal GIRK/KIR3 current that
was active without exogenous receptor activation, which may
be a confounder of results interpretation in the two studies.
Moreover, application of tertiapin Q after receptor activation
caused APD90 and ERP return close to baseline values but it did
not gave an overshoot that would be expected if the activation by
adenosine and acetylcholine only affected GIRK/KIR3-mediated
currents. This phenomenon was interpreted as a reflection of
multiple downstream targets of Gi receptors, which may include
activation of Cav1.3 (L-type) channels that would contribute
to sustain ionotropy (Wang et al., 2013). The molecular
mechanisms underlying the coupling of Cav1 and KCa2/SK
channels are unknown. Functional coupling of Cav1.3 (L-type)
and KCa2/SK channels has been described in atrial myocytes
via the cytoskeletal protein α-actinin2, an F-actin cross-linking
protein directly bridging C-terminal regions of both channels
(Lu et al., 2007). An indirect pathway requiring binding of Ca2+
to calmodulin (CaM), which then bounds to a CaM-binding
domain on the intracellular subunit of the SK channel, has also
been proposed. Here, we showed that adenosine A1 receptors
exerts a dual role by activating GIRK/KIR3 and inactivating KCa
2/SK mediated outward currents, with the latter being revealed
at a test potential of +40mV after transient activation of high-
voltage Cav1 (L-type) channels by a brief (50 ms) depolarizing
pulse to−10mV (Grant, 2009). Upon blocking GIRK/KIR3.1/3.4
channels with tertiapin Q, the A1 receptor agonist decreased,
rather than increased, the outward component and this effect
was fully prevented by co-application of the KCa2/SK channel
blocker apamin. These findings clearly indicate that the net
GIRK/KIR3.1/KIR3.4 outward current triggered by adenosine
that is responsible for reducing the SA node automatism may
be partially counteracted by the inactivation of an apamin-
sensitive Ca2+-activated KCa2/SK repolarizing current leading to
prolongation of action potential duration and to Ca2+ influx into
atrial cardiomyocytes via voltage-gated Cav1 (L-type) channels.
On its own, Ca2+ influx into cardiomyocytes may also influence
action potential duration through Ca2+-sensitive ionic currents,
such as the sodium-calcium exchanger and the calcium-sensitive
chloride current. Although there are several studies addressing
the effects of adenosine on potassium currents in atrial myocytes
(Kurachi et al., 1986; Banach et al., 1993; Wellner-Kienitz et al.,
2000; Lomax et al., 2003), to the best of our knowledge there is no
report showing that activation of the adenosine A1 receptor leads
to inactivation of an outward K+ current carried out by KCa2/SK
channels in these cells.
The (patho)physiological role of apparent opposite effects
on potassium currents caused by adenosine A1 receptors
activation is under debate. Our study suggests that inhibition
of KCa2/SK channels by adenosine plays a remarkable role
on atrial inotropy. These findings seem to be reliable because
blockade of KCa2/SK channels cause a delay in the late
phase of the cardiac repolarization (Xu et al., 2003; Tuteja
et al., 2005; but see Nagy et al., 2009; Hancock et al.,
2015). According to the most accepted hypothesis to explain
negative inotropic effects uponGIRK/KIR3.1/3.4 channels (Wang
and Belardinelli, 1994; Ford and Broadley, 1999), inhibition
of cardiac repolarizing K+ currents, such as the apamin-
sensitive small conductance Ca2+-activated KCa2/SK current,
may increase the time available for Ca2+ influx via Cav1 (L-
type) channels due to action potential prolongation and this
might counteract the negative inotropic effects promoted by
K+ eﬄux through GIRK/KIR3.1/3.4 channels. In addition to the
enrolment of KCa2/SK channels on atrial inotropic mechanisms,
these channels have been identified as key players in the course
of supraventricular arrhythmias (Li et al., 2009; Yu et al., 2012),
which is particularly interesting in a context of anti- and pro-
arrhythmic properties of adenosine and its derivates (Kabell et al.,
1994; Bertolet et al., 1997; Lim et al., 2009). Further studies
remain to be performed to elucidate if KCa2/SK channels are
exclusively modulated by adenosine A1 receptors, but at this
moment our data suggests that cardiac muscarinic M2 receptors
do not play a role in this mechanism.
Besides the involvement of various K+ channel subtypes, the
electrophysiological activity of atrial myocytes involves Ca2+
influx by Cav1 (L-type) voltage-sensitive channels (Amin et al.,
2010). Novel studies describe the Cav1.3 channel as a determinant
of human heart rate but not of ventricular excitation-contraction
coupling, which depends mainly on Ca2+ influx through the
Cav1.2 channel isoform (Baig et al., 2011). Confocal microscopy
data showed that immunoreactivity against Cav1 (L-type), using
an antibody specific for the regulatory α2δ subunit of the channel
that does not target subtype-specific α1 subunits, was consistently
distributed in both SA node and right atrium. Voltage-sensitive
Cav1 (L-type) channels are blocked by organic antagonists. These
include dihydropyridines (nifedipine) and phenylalkylamines
(verapamil), but only the second has cardioselective activity
with useful clinical indications to normalize tachycardia rhythms
(Grant, 2009). However, little is known about the functional
interactions between adenosine and Cav1 (L-type) channel
blockers on atrial activity despite the two compounds are
often used in line to revert supraventricular dysrhythmias. Our
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findings clearly demonstrate for the first time that blockade of
Cav1 (L-type) channels by nifedipine and verapamil predisposes
atria to the negative inotropic action of adenosine probably by
uncoupling A1-receptor-mediated KCa2/SK channel inhibition
from its effector system, the Cav1 (L-type) subtype channel.
Further studies are required to investigate the interplay of the
two channels vis a vis A1 receptors activation. Contrariwise,
nifedipine and verapamil were devoid of effect on muscarinic
M2-receptor-mediated actions on spontaneously beating rat
atria. This disparity is in agreement with literature. Unlike the A1
receptor, activation of the muscarinic M2 receptor in the heart
might not affect Cav1 (L-type) currents (De Biasi et al., 1989;
Song and Belardinelli, 1994; Belardinelli et al., 1995), although
both receptors may co-localize and share a common pathway
leading to hyperpolarization of atrial myocytes via K+ eﬄux
through GIRK/KIR3.1/3.4 channels (Belardinelli and Isenberg,
1983; Kurachi et al., 1986).
Receptor reserve refers to a phenomenon whereby stimulation
of only a fraction of the whole receptor population apparently
elicits the maximal effect achievable in a particular tissue
depending on agonists efficacy and on the pathways activated
to cause signal amplification (reviewed in Dhalla et al., 2003;
Kenakin, 2009). If the receptor reserve is small for a given agonist,
the agonist will only elicit the effect in a significant extent when
used at high concentrations, while the same agonist can produce
the effect even in low concentrations if the receptor reserve is
high. Previous studies indicate that atrial cardiomyocytes possess
a substantial A1 receptor reserve for the direct negative inotropy,
which is greater than the A1 receptor reserve for any other effects
in the guinea-pig atrium paced electrically at 3Hz-frequency
(Gesztelyi et al., 2013; Kiss et al., 2013). Taking this into account,
one would predict that enzymatically-stable full A1 receptor
agonists, such as R-PIA, should be more potent in decreasing
the contractile force than the atrial rate. Yet, we show here that
bradycardia produced by R-PIA predominates over the negative
inotropic effect of the A1 receptor agonist in spontaneously
beating isolated rat atria. Whether increases in atrial A1 receptor
reserve specifically for the direct negative inotropy occur in
the presence of the KCa2/SK blocker, apamin, or of Cav1
(L-type) channel inhibitors, nifedipine or verapamil, deserve
future investigations as they may sensitize atria to mechanical
depression in clinical conditions requiring administration of
adenosine followed by verapamil for conversion of paroxysmal
supraventricular tachycardia.
CONCLUSION
In conclusion, this study contributes to elucidate the
pharmacology of the ionic mechanisms responsible for
adenosine chronoselectivity via adenosine A1 receptors
activation in spontaneously beating rat atria as compared with
other cardiodepressant agents, like those activating muscarinic
M2 receptors and inhibiting voltage-sensitive Cav1 (L-type)
channels. Activation of the adenosine A1 receptor decreases SA
node automatism mainly by promoting K+ eﬄux through βγ
subunits of G protein-coupled inwardly rectifying GIRK/KIR3
channels. This effect, may be counteracted by inhibition of
KCa2/SK currents (probably via G protein α subunit) leading
to a subsequent prolongation of atrial repolarization. The
increase in the time available for Ca2+ influx through voltage-
sensitive Cav1 (L-type) channels may be essential to sustain
inotropy in the presence of the adenosine A1 receptor agonist
in concentrations causing significant negative chronotropic
actions. We are aware that this hypothesis is not consensual
therefore detailed electrophysiological studies are warranted to
determine precisely whether or not activation of the adenosine
A1 receptor contributes to prolongation of action potentials in
atrial cardiomyocytes. Although Ca2+ transients are certainly
important determinants of atrial contractility, further studies
are required to investigate how they integrate with mechanisms
regulating the ultimate step of cardiac contractility, the
myofilament Ca2+ sensitivity and cross-bridging, which may
also conceivably be altered by A1 receptors stimulation (see
e.g., Strang et al., 1995). Even so, our findings might be of
clinical relevance, as conversion of paroxysmal supraventricular
tachycardia to sinus rhythm may involve different sequences
of intravenous drugs administrations including adenosine
(or its stable derivative, tecadenoson) and/or Cav1 (L-type)
channel inhibitors (e.g., verapamil) (Lim et al., 2009). Thus,
loss of adenosine chronoselectivity and atrial sensitization to
the negative inotropic action of A1 receptors by Cav1 (L-type)
channel blockers may have deleterious effects in critical patients
whenever adenosine is used concomitantly with verapamil.
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Supplementary Figure 1 | Concentration-response curves of adenosine on
rate (chronotropy) and mechanical tension (inotropy) of spontaneously
beating atria. Adenosine (0.001–3mM) was applied once every 2 min at
increasing concentrations. The ordinates are percentage of variation from baseline
spontaneous contractions. The data are expressed as mean ± SEM from an n
number of individual experiments. ∗P < 0.05 compared with adenosine-induced
percentage of baseline variation on chronotropy.
Supplementary Figure 2 | Effect of increasing the extracellular
concentration of potassium from 2.7 (Control) to 4.7mM on the negative
chronotropic and inotropic effects of oxotremorine (A,B) and R-PIA (C,D)
on spontaneously beating rat atria. The ordinates are percentage of variation
of spontaneous contraction rate (chronotropic effect, A,C) and mechanical tension
(inotropic effect, B,D) compared to baseline values obtained before increasing the
KCl concentration to 4.7mM. Data are expressed as mean ± SEM from an n
number of individual experiments. ∗P < 0.05 compared with the effect of
oxotremorine or R-PIA in control conditions.
Supplementary Figure 3 | Higher-magnification representative confocal
micrographs of rat right atrium and SA node sections shown in Figure 5.
Immunofluorescence stainings for KIR3.1 (GIRK1) and CaVα2δ−1 channel
subunits appear in green. Cell nuclei are stained in blue with DAPI. The
corresponding differential interference contrast (DIC) images are also shown for
comparison (last row). Similar results were obtained in five additional experiments.
Supplementary Figure 4 | Higher-magnification representative confocal
micrographs of rat right atrium and SA node sections shown in Figure 5.
Immunofluorescence stainings for KCa2.2 (SK2) and KCa2.3 (SK3) channel
subunits appear in green. Cell nuclei are stained in blue with DAPI. The
corresponding differential interference contrast (DIC) images are also shown for
comparison (last row). Similar results were obtained in five additional experiments.
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